Danaher Co. (NYSE:DHR) Shares Sold by 1900 Wealth Management LLC

1900 Wealth Management LLC lowered its position in Danaher Co. (NYSE:DHR) by 10.6% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 2,032 shares of the conglomerate’s stock after selling 241 shares during the period. 1900 Wealth Management LLC’s holdings in Danaher were worth $470,000 at the end of the most recent quarter.

Other hedge funds have also recently modified their holdings of the company. Banco Santander S.A. acquired a new position in shares of Danaher during the 3rd quarter worth about $683,000. First Citizens Bank & Trust Co. raised its position in shares of Danaher by 0.6% during the 4th quarter. First Citizens Bank & Trust Co. now owns 26,611 shares of the conglomerate’s stock worth $6,156,000 after purchasing an additional 149 shares during the last quarter. Allspring Global Investments Holdings LLC raised its position in shares of Danaher by 48.1% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 296,996 shares of the conglomerate’s stock worth $68,707,000 after purchasing an additional 96,395 shares during the last quarter. Parkside Financial Bank & Trust grew its stake in Danaher by 4.8% during the 3rd quarter. Parkside Financial Bank & Trust now owns 3,080 shares of the conglomerate’s stock valued at $764,000 after acquiring an additional 142 shares in the last quarter. Finally, Keybank National Association OH grew its stake in Danaher by 0.5% during the 3rd quarter. Keybank National Association OH now owns 553,155 shares of the conglomerate’s stock valued at $137,238,000 after acquiring an additional 2,567 shares in the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Insiders Place Their Bets

In other Danaher news, SVP Georgeann Couchara sold 2,622 shares of the firm’s stock in a transaction dated Tuesday, February 13th. The stock was sold at an average price of $242.67, for a total transaction of $636,280.74. Following the transaction, the senior vice president now owns 4,244 shares in the company, valued at $1,029,891.48. The sale was disclosed in a document filed with the SEC, which is available through this link. In other Danaher news, SVP Georgeann Couchara sold 2,622 shares of the business’s stock in a transaction that occurred on Tuesday, February 13th. The stock was sold at an average price of $242.67, for a total transaction of $636,280.74. Following the transaction, the senior vice president now owns 4,244 shares of the company’s stock, valued at approximately $1,029,891.48. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Daniel Raskas sold 23,757 shares of the business’s stock in a transaction that occurred on Monday, February 26th. The stock was sold at an average price of $252.00, for a total value of $5,986,764.00. Following the transaction, the senior vice president now directly owns 38,102 shares in the company, valued at approximately $9,601,704. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 32,957 shares of company stock worth $8,265,802. Insiders own 10.90% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on DHR shares. Raymond James upped their price objective on shares of Danaher from $240.00 to $270.00 and gave the company an “outperform” rating in a research note on Wednesday, January 31st. Barclays increased their price target on shares of Danaher from $240.00 to $260.00 and gave the company an “equal weight” rating in a research note on Wednesday, April 10th. KeyCorp increased their price target on shares of Danaher from $260.00 to $290.00 and gave the company an “overweight” rating in a research note on Thursday, February 1st. StockNews.com cut shares of Danaher from a “buy” rating to a “hold” rating in a research note on Wednesday, January 31st. Finally, Royal Bank of Canada increased their price target on shares of Danaher from $254.00 to $282.00 and gave the company an “outperform” rating in a research note on Wednesday, January 31st. Six investment analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $268.27.

Danaher Price Performance

Danaher stock traded up $16.88 during mid-day trading on Tuesday, hitting $252.96. 2,901,397 shares of the company were exchanged, compared to its average volume of 2,724,830. The company has a quick ratio of 1.37, a current ratio of 1.68 and a debt-to-equity ratio of 0.31. The business has a fifty day moving average of $248.72 and a 200 day moving average of $230.39. Danaher Co. has a 1-year low of $182.09 and a 1-year high of $259.00. The company has a market capitalization of $187.33 billion, a PE ratio of 39.46, a price-to-earnings-growth ratio of 3.95 and a beta of 0.83.

Danaher (NYSE:DHR) last announced its earnings results on Tuesday, January 30th. The conglomerate reported $2.09 earnings per share for the quarter, beating analysts’ consensus estimates of $1.91 by $0.18. Danaher had a return on equity of 12.25% and a net margin of 17.26%. The company had revenue of $6.41 billion during the quarter, compared to analyst estimates of $6.10 billion. During the same period last year, the company posted $2.87 earnings per share. The firm’s quarterly revenue was down 10.2% compared to the same quarter last year. As a group, sell-side analysts expect that Danaher Co. will post 7.62 earnings per share for the current year.

Danaher Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, April 26th. Investors of record on Thursday, March 28th will be issued a $0.27 dividend. This is a boost from Danaher’s previous quarterly dividend of $0.24. The ex-dividend date is Wednesday, March 27th. This represents a $1.08 annualized dividend and a yield of 0.43%. Danaher’s dividend payout ratio (DPR) is currently 16.90%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.